AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letrozar 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Tetra Healthcare India

Salt Composition

Letrozole (2.5mg)

Overview Letrozar 2.5 Tablet

Post-menopausal women with breast cancer may find relief with Letrozar 2.5mg tablets. This medication can be a standalone treatment or used alongside surgery or radiotherapy. In advanced cases, it helps prevent cancerous spread. Letrozar 2.5mg tablets may be taken with or without food, always adhering to your doctor's prescribed dosage and schedule for optimal results. Dosage varies depending on the treatment goal, determined by your physician to best manage your condition. Continue taking the medication as directed. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Disclose all other medications you're currently using, as interactions may affect Letrozar's efficacy. Pregnancy or breastfeeding should also be discussed with your doctor. Blood tests monitoring vitamin D levels and bone density may be conducted before and throughout treatment.

Uses of Letrozar 2.5 Tablet

Managing breast cancer

Major Benefits of Letrozar 2.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. You can take Letrozar 2.5 Tablet with or without food, but consistency in timing is recommended.

Common Side effects of Letrozar 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrozar 2.5 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Letrozar 2.5mg Tablets can be administered with or without food, although consistent timing is recommended.

How Letrozar 2.5 Tablet works:

Femara 2.5mg tablets are classified as aromatase inhibitors. Their mechanism of action involves reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Letrozar 2.5 Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Administering Letrozar 2.5 mg tablets to pregnant individuals poses a substantial risk. Preclinical and clinical research indicates considerable harm to the fetus, mandating consultation with a healthcare professional before use.

Breast feedingBreast feedingUNSAFE

Administering Letrozar 2.5 mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking a 2.5mg Letrozar tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The 2.5 mg Letrozar tablet is considered safe for patients with kidney disease, and no dosage modification is typically needed. Data on its use in patients with end-stage renal disease, however, is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Letrozar 2.5 mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

What if you forget to take Letrozar 2.5 Tablet :

Should you forget a Letrozar 2.5 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letrozar 2.5 Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Good Habits No.
Treatment Category Cancer Medications

FAQs on Letrozar 2.5 Tablet

Letrozole 2.5 mg tablets are an aromatase inhibitor used to treat breast cancer in postmenopausal women.
Letrozole 2.5 Tablet is an anti-estrogen medication. It works by inhibiting the aromatase enzyme, thereby decreasing estrogen production. Because estrogen fuels the growth of certain breast cancers—known as estrogen-dependent cancers—reducing estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letrozar 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Letrozar 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letrozar 2.5 Tablet followed by three years of tamoxifen may be used.
It's safe to combine irbesartan and Letrozar 2.5 Tablet, but monitor your blood pressure closely as Letrozar 2.5 Tablet can raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrozar 2.5 Tablet may lead to cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flashes may indicate a common side effect of Letrozar 2.5 Tablet, resulting from lowered estrogen levels. These usually lessen as your body adapts, though some may persist throughout treatment, subsiding several months afterward. For persistent, bothersome hot flashes, consult your doctor for management options.
While rare, Letrozar 2.5 Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrozar 2.5 Tablets can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Letrozar 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Letrozar 2.5 Tablet
252
MRP 293
13% off